В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...знями и группами болезней, их элиминации или полной ликвидации. В ней также определены сквозные целевые показатели, согласованные с Тринадцатой общей программой работы ВОЗ и Целями в области устойчивого развития, а также стратегии по достижению этих целевых
показателей в течение ближайших десяти лет.
more
The WHO report on health preparedness for El Niño 2015-2016 describes the impact of this weather phenomenon on global public health. Strong El Niño events lead to extreme weather conditions, including droughts, floods, and storms, which increase the risk of diseases such as cholera, malaria, and d...engue fever. Particularly affected regions include Africa, Asia-Pacific, and Latin America, where water and food shortages and disease outbreaks are becoming more frequent.
The WHO supports countries through risk assessments, emergency plans, and disease surveillance to prevent outbreaks. Recommended measures include early warning systems, health preparedness in vulnerable areas, and better coordination between health and meteorological services to minimize the negative effects of El Niño on public health.
more
L’objectif des lignes directrices 2024 est de fournir des recommandations actualisées et fondées sur
des données probantes sur les principaux sujets prioritaires. Ceux-ci concernent notamment les critères élargis et simplifiés de mise sous traitement pour les adultes, mais aussi désormais ...pour les adolescents, l’élargissement des critères d’éligibilité au traitement
antiviral prophylactique pour les femmes enceintes
afin de prévenir la transmission mère-enfant du VHB,
l’amélioration des tests de diagnostic de l’infection par le
VHB grâce à l’utilisation de tests de mesure de la charge
virale du VHB (ADN) sur le lieu de soins (“point-of-care
tests”) et d’approches réflexes pour la recherche de
l’ADN du VHB, et les critères pour déterminer à qui et
comment faire le test pour rechercher une infection par
le VHD.
more
• تشكّل مقاومة مضادات الميكروبات تهديداً عالمياً للصحة والتنمية، وهي تستدعي اتخاذ إجراءات عاجلة متعددة القطاعات بشأنها من أجل تحقيق أهداف التنمية المستدامة.
أعلن...ت المنظمة أن مقاومة مضادات الميكروبات من التهديدات العالمية العشرة الرئيسية للصحة العامة التي تواجه البشرية.
تعدّ إساءة استعمال مضادات الميكروبات والإفراط في استعمالها المحركان الرئيسيان لظهور المُمرضات المقاومة للأدوية.
يؤدي نقص المياه النظيفة وخدمات الإصحاح وقصور الوقاية من عدوى الأمراض ومكافحتها إلى تعزيز انتشار الميكروبات التي يمكن لبعضها أن يقاوم العلاج بمضادات الميكروبات.
يترتب على مقاومة مضادات الميكروبات تكاليف طائلة. وإضافة إلى ما تخلفه الاعتلالات الممتدة لأجل طويل من وفيات وإعاقات، فإنها تسفر عن إطالة أمد رقود المرضى في المستشفيات وحاجتهم إلى أدوية أغلى ومواجهتهم لتحديات مالية.
من شأن نجاح الطب الحديث في حالات العدوى، بوسائل منها العمليات الجراحية الكبرى والعلاج الكيميائي للسرطان، أن يتعرض لمخاطر متزايدة من دون استعمال مضادات ميكروبات ناجعة.
more
WHO recommends prompt recognition of progressive acute hypoxaemic respiratory failure when a patient with respiratory distress is failing to respond to standard oxygen therapy and adequate preparation to provide advanced oxygen/ventilatory support.
Hypoxaemic respiratory failure in ARDS commonly ...results from intrapulmonary ventilation-perfusion mismatch or shunt and usually requires mechanical ventilation.
At any time, if there are urgent or emergent indications for intubation, do not delay.
We recommend prompt recognition of progressive acute hypoxaemic respiratory failure when a patient with respiratory distress is failing to respond to standard oxygen therapy and adequate preparation to provide advanced oxygen/ventilatory support.
WHO suggests that patients with severe or critical COVID-19 with acute hypoxaemic respiratory failure that do not require emergent intubation be treated with HFNO, or CPAP or NIV (BiPAP) over standard oxygen therapy.
more
These guidelines aim to guide all health care providers in Myanmar, accommodating the situation of different settings in the context of progressive decentralization of HIV services. Notable changes from the previous edition include:
• diagnosis of HIV
• update on the initiation of ART<...br>
• new ARV drugs and regimens
• new recommendation on infant prophylaxis
• PrEP and PEP updates
• updates on co-infections and comorbidities management
It should be noted that these guidelines are meant for the operational level and are adapted and adopted in line with existing Myanmar context.
more
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug... Monitoring. This text was developed in consultation with the WHO Collaborating Centre for International Drug Monitoring and the national pharmacovigilance centres participating in the WHO Programme for International Drug Monitoring.
more
Caring for the Sick Child age 2 months up to 5 years. Chart Booklet
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and e...xtensively drug-resistant tuberculosis.
more
This provisional Facilitator's Kit provides a complete framework for a 3-day training on Community Preparedness for Reproductive Health and Gender. The goal is to build community capacity to prepare and respond to risks and inequities faced by women and girls during emergencies.
This document provides interim recommendations for the surveillance of Zika virus infection, microcephaly and Guillain-Barré syndrome, in four different contexts and describes reporting requirements to WHO. Transmission refers to vector-borne transmission, unless specified differently. Autochthonou...s infection is considered to be an infection acquired in-country, i.e. among patients with no history of travel during the incubation period or who have travelled exclusively to non-affected areas during the incubation period. This document does not provide guidance on laboratory investigation or vector surveillance.
more
Medical care for people caught up in armed conflict and other insecure environments saves lives and alleviates suffering. It is one of the most immediate and high priority needs of an affected population and is often the first type of response activated and/or requested by authorities and affected c...ommunities. Medical teams working in armed conflict and other insecure environments
frequently face serious threats to their security and safety, challenges to patient access, and at times limited acceptance by affected communities in which they work and parties to the conflict. Such difficulties are likely to increase (6) and
thereby creating a critical need to establish contact and trust with all sides in conflicts and in other insecure environments to ensure operational continuity. This trust can best be achieved when all sides perceive the medical teams to be neutral, impartial, and independent, and specifically not aiding (or being perceived to aid) any one party to achieve a military, political or economic
advantage. For medical teams that are deploying increasingly closer to the frontlines, the implications of and consequences for both staff and patients of teams not being fully prepared, and/or not fully comprehending the context in which they work, can be severe. Medical response can easily be hindered or compromised by intentional or unintentional acts and the behaviour and
conduct of the teams themselves
more